Gadolinium-based Contrast Agent drugs compared
Compare all 4 Gadolinium-based Contrast Agent drugs side by side. They share one FDA-defined mechanism but differ in approved uses, prescription status, brand-vs-generic options, price, and FDA recall-safety record — which our independent rating scores.
Full ranking · 4 drugs
- 1New
gadavist
Gadobutrol
- 2New
gadobutrol
Gadobutrol
- 3New
multihance
Gadobenate Dimeglumine
- 4New
multihance multipack
Gadobenate Dimeglumine
Frequently asked questions
What is the Gadolinium-based Contrast Agent drug class?
Gadolinium-based Contrast Agent is an FDA Established Pharmacologic Class (EPC) — a group of drugs that share a mechanism of action. pharmaranks lists 4 Gadolinium-based Contrast Agent products, each independently rated.
Are all Gadolinium-based Contrast Agent drugs the same?
No. Gadolinium-based Contrast Agent drugs share the same core mechanism — that is why they sit in one FDA class — but they differ in their approved uses, available forms, whether they are prescription or over-the-counter, brand-vs-generic options and price, and their FDA recall-safety record.
Sources: the Gadolinium-based Contrast Agent class definition and its member drugs come from the U.S. NLM RxClass (Established Pharmacologic Class). Ratings are pharmaranks’ independent FDA recall-safety analysis.